ankylosing spondylitis in iran; late diagnosis and its causes

نویسندگان

mehrzad hajialilo connective tissue diseases research center, tabriz university of medical sciences, tabriz, ir iran

amir ghorbanihaghjo biotechnology research center, tabriz university of medical sciences, tabriz, ir iran; biotechnology research center, tabriz university of medical sciences, tabriz, ir iran. tel: +98-4113364666, fax: +98-4114426078

alireza khabbazi connective tissue diseases research center, tabriz university of medical sciences, tabriz, ir iran

suosan kolahi connective tissue diseases research center, tabriz university of medical sciences, tabriz, ir iran

چکیده

conclusions: in this study, delay in diagnosis was similar to other studies. educating physicians to careful history taking especially in the case of ibp, non-musculoskeletal symptoms such as uveitis and precise physical examination are important in early diagnosis. patients and methods: sixty patients, (53 males, 7 females) with a diagnosis of as according to the modified new york criteria were recruited. diagnosis delay was defined as the interval between a patient’s first spondyloarthritic symptoms [inflammatory back pain (ibp), inflammatory arthritis, enthesopathy and uveitis] and a correct diagnosis of as. results: the average age of patients at diagnosis of as was 36.4 ± 4.5 years and the average of delay in diagnosis was 6.2 ± 3.5 years. the most common diagnosis at the first visit was disc herniation (68.3%). delay in diagnosis of human leukocyte antigen (hla-b27) positive and negative patients were 4.6 ± 2.2 years and 10.1 ± 3.2 years, respectively (p = 0.0001). diagnosis delay in patients with morning stiffness and ibp were significantly shorter than that of patients without these symptoms (p = 0.0001 and p = 0.001, respectively). patients with uveitis had the shortest diagnosis delay (p = 0.02). the bath ankylosing spondylitis disease activity index (basdai) was not significantly different in early (< 3years) and late (> 3years) diagnosis (3.3 ± 0.9 and 3.6 ± 0.7, respectively) (p = 0.18), but the both ankylosing spondylitis functional index (basfi) was significantly different between them (3.3 ± 1.0 and 4.1 ± 0.7 respectively) (p = 0.001). background: ankylosing spondylitis (as) is a chronic destructive and inflammatory disease of the axial skeleton manifested by back pain and progressive stiffness of the spine. objectives: the aim of the present cross-sectional study was to evaluate and identify factors leading to delayed diagnosis of as in iranian patients.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Ankylosing Spondylitis in Iran; Late Diagnosis and Its Causes

BACKGROUND Ankylosing spondylitis (AS) is a chronic destructive and inflammatory disease of the axial skeleton manifested by back pain and progressive stiffness of the spine. OBJECTIVES The aim of the present cross-sectional study was to evaluate and identify factors leading to delayed diagnosis of AS in Iranian patients. PATIENTS AND METHODS Sixty patients, (53 males, 7 females) with a dia...

متن کامل

Urolithiasis in ankylosing spondylitis: Correlation with Bath ankylosing spondylitis disease activity index (BASDAI), Bath ankylosing spondylitis functional index (BASFI) and Bath ankylosing spondylitis metrology index (BASMI)

Background: Increased incidence of renal stone has been reported in ankylosing spondylitis (AS), but unlike some well-known renal involvements, they have not been fully studied. The aim of this study was to investigate the association of AS with urolithiasis and also the relation between urinary stone and severity markers. Methods: One hundred-sixty three AS patients were included in a cross-s...

متن کامل

ASSOCIATION OF HLA-B27 WITH ANKYLOSING SPONDYLITIS IN ISFAHAN, IRAN

Using a standard microcytotoxicity (NIH) technique of tissue typing, the HLA-B27 antigen was identified in 30 out of 34 patients (HH.2%) with classical ankylosing spondylitis (AS), compared to 6 out of 70 controls (H.6%) (P < 0.005). We also found this antigen in 8 out of 76 (10.5%) patients with non-AS arthritis.

متن کامل

Ankylosing spondylitis: diagnosis and management

This article provides an overview of ankylosing spondylitis, including signs and symptoms, diagnosis and management. The article focuses on the difficulties and delays associated with diagnosing this chronic inflammatory disease and developments in diagnostic criteria. Changes in the management of patients with the disease are also discussed, particularly in light of anti-tumour necrosis factor...

متن کامل

Ankylosing spondylitis: introductory comments on its diagnosis and treatment.

Ankylosing spondylitis (AS) is a chronic systemic inflammatory rheumatic disorder of uncertain aetiology that primarily affects the axial skeleton (sacroiliac joints and spine). Sacroiliac joint involvement (sacroiliitis) is its hallmark. The course of AS is highly variable and can be characterised by spontaneous remissions and exacerbation, particularly in early disease. The disease activity, ...

متن کامل

Early Diagnosis and Treatment in Ankylosing Spondylitis

THE neglected case of progressive ankylosing spondylitis is a tragedy. Like so many other disease processes, early diagnosis and appropriate therapeutic measures are essential if a satisfying result is to be obtained; particularly in this disease which is predominantly one of younger age groups. An analysis of a small series of patients, thirty-four in all, studied at the Northern Ireland Radio...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
iranian red crescent medical journal

جلد ۱۶، شماره ۴، صفحات ۰-۰

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023